JOURNAL OF THORACIC DISEASE, vol.5, no.5, pp.634-640, 2013 (SCI-Expanded)
Article / Article
JOURNAL OF THORACIC DISEASE
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Recep Tayyip Erdoğan University Affiliated:
Background and objective: Recent evidence suggests that YKL-40 is a relatively new biomarker of inflammation and it is involved in the pathogenesis of several pulmonary diseases. Details of serum and pleural YKL-40 in pleural effusions however, remain unknown. We aimed to assess whether serum and pleural YKL-40 is an accurate biomarker of pleural effusions.